Table 2 Methodological characteristics of clinical trials
Author | Year | Rand. | Alloc. | Blind. | Desc. losses | Sample Size | ITT | Multic. | Sponsor |
|---|---|---|---|---|---|---|---|---|---|
Zagars | 1988 | NS | NS | No | Yes | No | No | No | Public |
Laverdiere | 2004 | NS | NS | No | No | No | Ns | No | NS |
Lawton | 2005 | Yes | Yes | No | Yes | Yes | No | Yes | NS |
Granfors | 2006 | NS | NS | No | Yes | Yes | Yes | No | Public |
See | 2006 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Industry |
D'Amico | 2008 | Yes | Yes | No | Yes | Yes | Yes | Yes | Public |
Roach | 2008 | NS | NS | No | Yes | Yes | Yes | Yes | Public |
Bolla | 2010 | Yes | Yes | No | Yes | Yes | Yes | Yes | Both |
Denham | 2011 | Yes | Yes | No | Yes | Yes | No | No | Both |
Jones | 2011 | Yes | Yes | No | Yes | Yes | Yes | Yes | Public |